David Kandzari, MD
Enriched profileChief, Piedmont Heart Institute and Cardiovascular Service Line; Director, Interventional Cardiology; Chief Scientific Officer, Piedmont Healthcare · Piedmont Heart Institute
David Kandzari is Chief, Piedmont Heart Institute and Cardiovascular Service Line; Director, Interventional Cardiology; Chief Scientific Officer, Piedmont Healthcare at Piedmont Heart Institute. OpenAlex indexes 670 publications with 29,091 citations (h-index 82); ClinicalTrials.gov lists 32 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Interventional Cardiology profiles in the findmyKOL directory.
Data verified 25 Aug 2026
Overview
Updated 27 Aug 2026
David Kandzari, MD, is Chief, Piedmont Heart Institute and Cardiovascular Service Line. The public record shows 670 publications with 29,091 citations (h-index 82), centered on Coronary Interventions and Diagnostics, Cardiac Imaging and Diagnostics, Blood Pressure and Hypertension Studies. It also documents an investigator role on 32 registered clinical trials, industry payments reported by 25 companies.
- Most recent indexed publication: 2026 · Circulation. Cardiovascular interventions
- Top research focus: Coronary Interventions and Diagnostics
- 32 registered trials on ClinicalTrials.gov
- Open Payments reporting from 25 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 28 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 266.
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Public positions
sourced statements on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →fda.gov ↗
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 32 registered studies on ClinicalTrials.gov. The most recent:
- Renal Artery Denervation Assessment Without Antihypertensive Medication Regimen (RADAR)
Sponsor: Ablative Solutions, Inc.
Industry payments
Updated 27 Aug 2026
25 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Medtronic, Inc.Program year202528 payments$19,893openpaymentsdata.cms.gov ↗
- CORDIS US CORP.Program year20253 payments
- Boston Scientific CorporationProgram year20257 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
75.9%Statin25.2%Rosuvastatin Calcium69%Atorvastatin Calcium28%Simvastatin3%Part D<11 patientsBeta blocker12.7%Metoprolol Succinate60%Metoprolol Tartrate19%Carvedilol15%Atenolol6%Part D<11 patientsBlood & clotting
23.4%P2Y12 inhibitor19.7%Clopidogrel86%Prasugrel Hcl12%Brilinta3%Part D<11 patientsFactor Xa inhibitor3.7%Eliquis100%Part D≥22 patientsMetabolism & gastrointestinal
0.7%Potassium supplement0.7%Potassium Chloride100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Early Feasibility Study of a Novel Mechanical Circulatory Support Device for High-Risk PCI.
Circulation. Cardiovascular interventions
Article2026 - Three-Year Durability of Radiofrequency Renal Denervation: SPYRAL HTN-ON MED.
Journal of the American Heart Association
Clinical Trial2026 - Long-term outcomes following radiofrequency renal denervation: meta-analysis of 18 reports.
European journal of preventive cardiology
Meta-analysis2026 - Clinical Experience With a Novel Percutaneous LV Assist Device in High-Risk PCI: Primary Results From the SUPPORT I Study.
Circulation. Cardiovascular interventions
Article2026 - Calcium Modification After Orbital Atherectomy and Balloon Angioplasty in Severely Calcified Lesions: The ECLIPSE OCT Substudy.
Circulation. Cardiovascular interventions
Clinical Trial2026
Most-cited works
by citation count (OpenAlex)- 01A Controlled Trial of Renal Denervation for Resistant HypertensionArticle2,172 citations2014
- 02Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting StentsArticle1,911 citations2014
- 03Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery DiseaseArticle1,059 citations2016
- 04Clopidogrel Use and Long-term Clinical Outcomes After Drug-Eluting Stent ImplantationArticle872 citations2006
- 05Five-Year Outcomes after PCI or CABG for Left Main Coronary DiseaseArticle791 citations2019
Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/david-kandzari-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/david-kandzari-41b5908
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - ResearchGate
researchgate.net/scientific-contributions/David-E-Kandzari-39795224
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- Other
pcronline.com/Physicians/David-Kandzari
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →pcronline.com ↗ - Other
scai.org/david-e-kandzari-md-mscai
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scai.org ↗ - YouTube
youtube.com/watch
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- MD
Duke University Medical Center (1995); internship in cardiology, The Johns Hopkins Hospital (1996); residency, Johns Hopkins University School of Medicine (1998); fellowship in Interventional Cardiology …
1998verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →care.piedmont.org ↗ - Board certified
American Board of Internal Medicine - Cardiovascular Disease subspecialty and Interventional Cardiology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →care.piedmont.org ↗
Editorial & leadership roles
journal and society appointments- Fellow
American College of Cardiology (FACC)
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scai.org ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →care.piedmont.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →care.piedmont.org ↗
Secondary affiliations
appointments beyond the home institution- Advisor
European Cardiovascular Research Institute (ECRI)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ecri-trials.com ↗ - Leadership team
AVS Pulse, Inc.
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →avspulse.com ↗
Media & interviews
press, podcasts and appearances- Guest
Sensei Podcast Episode 107 - discussion of CTO and complex PCI
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗ - Late Breaking Clinical Trial Interview: BIONICS trial
video interview on TCTMD
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →tctmd.com ↗ - Guest
Living Real Change Podcast Episode Ten (Piedmont Healthcare) discussing heart health
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology